Jounce Therapeutics, Inc.

FMR LLC

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/11/2023

Shares

10,207

Value ($000)

19

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/11/2023	19	0.0%	10,207	3/31/2023
2022 Q4	2/13/2023	86	0.0%	77,798	12/31/2022
2022 Q3	11/10/2022	1,977	0.0%	844,787	9/30/2022
2022 Q2	8/12/2022	3,835	0.0%	1,265,811	6/30/2022
2022 Q1	5/13/2022	726	0.0%	106,964	3/31/2022
2021 Q4	2/14/2022	2,886	0.0%	345,631	12/31/2021
2021 Q3	2/14/2022	5,877	0.0%	790,934	9/30/2021
2021 Q2	8/13/2021	5,378	0.0%	790,934	6/30/2021
2021 Q1	5/14/2021	7,610	0.0%	741,034	3/31/2021
2020 Q4	2/8/2021	824	0.0%	117,774	12/31/2020
2020 Q3	11/13/2020	1,329	0.0%	162,874	9/30/2020
2020 Q2	8/24/2020	3,891	0.0%	563,974	6/30/2020
2020 Q1	5/14/2020	2,679	0.0%	563,974	3/31/2020
2019 Q4	2/7/2020	10,814	0.0%	1,238,774	12/31/2019